CFO
AMGN icon

Callan Family Office’s Amgen AMGN Stock Holding History

Callan Family Office’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Sell
31,795
-1,557
-5% -$533K 0.23% 82
2026
Q1 		$11.7M Sell
33,352
-1,091
-3% -$389K 0.27% 74
2025
Q4 		$11.3M Buy
34,443
+4,786
+16% +$1.52M 0.24% 80
2025
Q3 		$8.37M Sell
29,657
-1,299
-4% -$377K 0.27% 78
2025
Q2 		$8.64M Buy
30,956
+16,247
+110% +$4.6M 0.27% 73
2025
Q1 		$4.58M Buy
14,709
+764
+5% +$226K 0.34% 64
2024
Q4 		$3.63M Buy
13,945
+11,801
+550% +$3.5M 0.23% 82
2024
Q3 		$691K Buy
2,144
+150
+8% +$49.1K 0.12% 85
2024
Q2 		$623K Buy
1,994
+825
+71% +$242K 0.12% 73
2024
Q1 		$332K Buy
+1,169
New +$342K 0.08% 74

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Callan Family Office's AMGN Position: Q2 2026 in Review

Callan Family Office reduced its Amgen (AMGN) stake by 4.7% in Q2 2026, selling an estimated $533K and leaving 31,795 shares worth $11.5M. The position accounts for 0.23% of the portfolio, ranked #82.

Callan Family Office first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $11.7M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Callan Family Office held 31,795 shares of Amgen worth $11.5M as of Q2 2026.
  • Callan Family Office sold 1,557 Amgen shares in Q2 2026, an estimated $533K.
  • Amgen made up 0.23% of Callan Family Office's portfolio in Q2 2026, its #82 holding.
  • Callan Family Office first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • Callan Family Office's Amgen position peaked at $11.7M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.